Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |